Vivolta is a leading player in the development and implementation of electrospinning processes and equipment for the manufacture of medical devices for (regenerative) medicine and drug delivery.

Vivolta has developed a unique set of innovations in electrospinning technology for the reproducible and scalable production of electrospun material under tightly controlled conditions required by the med-tech and pharma markets.

The Dutch deep-tech company is actively committed to growth and international expansion of co-development processes in, among others, the med-tech and pharma industries.

Implants produced with the technology of Vivolta have proven to repair, replace and restore tissues and organ structures in the human body. Multiple products manufactured using this technology are now either on the market or in clinical development.

We invested in Vivolta from our Evergreen Fund.